197 related articles for article (PubMed ID: 32767766)
1. An Open-Label Study Evaluating the Pharmacokinetics and Safety of Diclofenac Potassium for Oral Solution for the Acute Treatment of MWA or MWoA in Pediatric Participants.
McVige JW; Hogan RM; Shanahan CM; Amend DL; Ferger SM
Headache; 2020 Oct; 60(9):1939-1946. PubMed ID: 32767766
[TBL] [Abstract][Full Text] [Related]
2. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
3. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
[TBL] [Abstract][Full Text] [Related]
4. Effects of food intake on the pharmacokinetics of diclofenac potassium soft gelatin capsules: a single-dose, randomized, two-way crossover study.
Scallion R; Moore KA
Clin Ther; 2009 Oct; 31(10):2233-41. PubMed ID: 19922894
[TBL] [Abstract][Full Text] [Related]
5. Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers.
Lissy M; Stiff DD; Kowalski MM; Moore KA
Curr Med Res Opin; 2009 Oct; 25(10):2423-8. PubMed ID: 19663688
[TBL] [Abstract][Full Text] [Related]
6. Diclofenac potassium powder for oral solution: a review of its use in patients with acute migraine.
Garnock-Jones KP
CNS Drugs; 2014 Aug; 28(8):761-8. PubMed ID: 25034250
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetic parameters of a single dose of a novel nano-formulated, lower-dose oral diclofenac.
Manvelian G; Daniels S; Gibofsky A
Postgrad Med; 2012 Jan; 124(1):117-23. PubMed ID: 22314121
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.
Desjardins PJ; Olugemo K; Solorio D; Young CL
Clin Ther; 2015 Feb; 37(2):448-61. PubMed ID: 25499666
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical Trials.
Ashina M; Goadsby PJ; Dodick DW; Tepper SJ; Xue F; Zhang F; Brennan F; Paiva da Silva Lima G
JAMA Neurol; 2022 Feb; 79(2):159-168. PubMed ID: 34928306
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of diclofenac sodium softgel 100 mg with or without caffeine 100 mg in migraine without aura: a randomized, double-blind, crossover study.
Peroutka SJ; Lyon JA; Swarbrick J; Lipton RB; Kolodner K; Goldstein J
Headache; 2004 Feb; 44(2):136-41. PubMed ID: 14756851
[TBL] [Abstract][Full Text] [Related]
11. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days.
Riff DS; Duckor S; Gottlieb I; Diamond E; Soulier S; Raymond G; Boesing SE
Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: results from the International Migraine Pain Assessment Clinical Trial (IMPACT).
Lipton RB; Grosberg B; Singer RP; Pearlman SH; Sorrentino JV; Quiring JN; Saper JR
Cephalalgia; 2010 Nov; 30(11):1336-45. PubMed ID: 20959428
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence study of low-dose diclofenac potassium tablet formulations.
Hinz B; Hug AM; Fotopoulos G; Gold MS
Int J Clin Pharmacol Ther; 2009 Oct; 47(10):643-8. PubMed ID: 19825328
[TBL] [Abstract][Full Text] [Related]
14. [Intramuscular diclofenac in the acute treatment of migraine: a double-blind placebo controlled study].
Bigal ME; Bordini CA; Speciali JG
Arq Neuropsiquiatr; 2002 Jun; 60(2-B):410-5. PubMed ID: 12131942
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of placebo use in migraine without aura, migraine with aura and episodic tension-type headache acute attacks].
Bigal ME; Bigal JO; Bordini CA; Speciali JG
Arq Neuropsiquiatr; 2001 Sep; 59(3-A):552-8. PubMed ID: 11588634
[TBL] [Abstract][Full Text] [Related]
16. A pharmacokinetic analysis of diclofenac potassium soft-gelatin capsule in patients after bunionectomy.
Kowalski M; Stoker DG; Bon C; Moore KA; Boesing SE
Am J Ther; 2010; 17(5):460-8. PubMed ID: 19531931
[TBL] [Abstract][Full Text] [Related]
17. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
[TBL] [Abstract][Full Text] [Related]
18. Diclofenac potassium 25 mg liquid capsules: earlier and higher exposure to diclofenac. A fasted, single-dose, comparative bioavailability study vs. diclofenac potassium 2 x 12.5 mg tablets.
Armogida M; Gold M
Int J Clin Pharmacol Ther; 2012 Jun; 50(6):445-51. PubMed ID: 22677306
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).
Winner P; Farkas V; Štillová H; Woodruff B; Liss C; Lillieborg S; Raines S;
Headache; 2016 Jul; 56(7):1107-19. PubMed ID: 27329280
[TBL] [Abstract][Full Text] [Related]
20. Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine-Associated Nausea and Prior Triptan Use on Efficacy.
Lipton RB; Schmidt P; Diener HC
Headache; 2017 May; 57(5):756-765. PubMed ID: 28386945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
